查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462942

免疫细胞工程市场，按细胞类型、按产品类型、按疾病适应症、按应用、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Immune Cell Engineering Market, By Cell Type, By Product Type, By Disease Indication, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 385 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年免疫细胞工程市场规模为29.225亿美元，2024年至2032年复合CAGR为20.5%。

免疫细胞工程市场-市场动态

对先进细胞疗法的需求不断增加，推动市场需求

鑑于对先进细胞疗法的需求不断增长，免疫细胞工程的全球市场为该领域的公司提供了利润丰厚的前景。使用工程化 T 细胞或嵌合抗原受体 (CAR) T 细胞的疗法在癌症治疗的临床试验中已显示出有希望的结果。主要市场驱动因素包括主要製药公司对免疫疗法的大量投资以及专注于免疫细胞疗法的临床试验的扩大。基因编辑、细胞分离和扩增技术的持续进步极大地推动了免疫细胞工程领域的扩张。 CRISPR/Cas9等有效基因编辑工具的出现促进了免疫细胞的精确且更安全的改变。同时，微流体和高通量分析等技术的进步正在简化细胞工程过程。此外，对免疫细胞讯号通路和相互作用的深入理解正在促进更有效的免疫细胞疗法的开发。这些持续的技术进步预计将拓宽工程免疫细胞的视野和实用性。

免疫细胞工程市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 20.5% 左右的CAGR成长

根据细胞类型细分，预计 T 细胞将在 2023 年显示最大的市场份额

从应用细分来看，细胞治疗与再生医学是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

免疫细胞工程市场-細項分析：

全球免疫细胞工程市场根据细胞类型、产品类型、疾病适应症、应用和区域进行细分。

市场依细胞类型分为六类：T 细胞、NK 细胞、树突状细胞、肿瘤细胞、干细胞等。在免疫细胞工程市场中，T细胞在细胞类型中占据主导地位。 T 细胞是免疫系统中的关键角色，具有识别和消除感染细胞或癌细胞的能力。它们的主导地位源于其多功能性以及在各种免疫疗法中的关键作用，特别是在 CAR T 细胞治疗中。该疗法涉及修改 T 细胞以表达嵌合抗原受体 (CAR)，使它们能够精确瞄准并摧毁癌细胞。随着 CAR T 细胞疗法在癌症治疗中越来越受欢迎，对工程 T 细胞的需求持续增长，推动了它们在市场上的主导地位。

市场依应用分为三类：研究应用、细胞治疗及再生医学等。在应用方面，细胞治疗和再生医学占据主导地位。这种主导地位归因于免疫细胞工程在开发针对各种疾病的新型细胞疗法方面的变革潜力。细胞疗法利用 T 细胞和干细胞等工程免疫细胞的治疗潜力来治疗癌症、自体免疫疾病和再生医学应用。尤其是 CAR T 细胞疗法，透过提供具有显着临床效果的个人化和标靶治疗，彻底改变了癌症治疗。此外，再生医学领域利用工程免疫细胞来修復和再生受损的组织和器官，为创新治疗方法铺平了道路。免疫细胞疗法的重大临床成功和广泛的治疗应用使细胞治疗和再生医学成为免疫细胞工程市场的主导应用。

免疫细胞工程市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

免疫细胞工程市场-竞争格局：

免疫细胞工程公司正在采取专注于创新、协作和市场扩张的策略。他们投资研究以增强 CAR T 细胞疗法等疗法，建立技术交流合作伙伴关係，并拓展新市场。这些努力旨在解决个人化治疗开发的复杂性、扩大生产能力并降低成本，最终目标是让更多患者获得治疗。此外，他们利用不断增长的临床证据和合作伙伴关係来推动免疫细胞工程的长期市场发展。

2023 年 8 月，製药公司 Astellas Pharma, Inc. 与临床阶段公司 Poseida Therapeutics 达成策略性投资协议，以推动癌细胞疗法的开发。安斯泰来承诺总共投入 5000 万美元，包括一次性付款 2500 万美元，以获得独家谈判权和优先拒绝许可 Poseida 的临床阶段项目之一 P-MUC1C-ALLO1。本计画重点在于开发针对各种实体肿瘤适应症的同种异体嵌合抗原 T 细胞 (CAR-T) 疗法。

目录

第一章：免疫细胞工程市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按细胞类型分類的免疫细胞工程市场片段
    • 按产品类型分類的免疫细胞工程市场片段
    • 按疾病适应症分類的免疫细胞工程市场片段
    • 免疫细胞工程市场片段（依应用）
    • 按国家/地区分類的免疫细胞工程市场片段
    • 按地区分類的免疫细胞工程市场片段
  • 竞争洞察

第 3 章：免疫细胞工程主要市场趋势

  • 免疫细胞工程市场驱动因素
    • 市场驱动因素的影响分析
  • 免疫细胞工程市场限制
    • 市场限制影响分析
  • 免疫细胞工程市场机会
  • 免疫细胞工程市场未来趋势

第四章：免疫细胞工程产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：免疫细胞工程市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：免疫细胞工程市场格局

  • 2023 年免疫细胞工程市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：免疫细胞工程市场 - 按细胞类型

  • 概述
    • 按电池类型分類的细分市场份额分析
    • T细胞
    • 自然杀手细胞
    • 树突状细胞
    • 肿瘤细胞
    • 干细胞
    • 其他的

第 8 章：免疫细胞工程市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 耗材
    • 仪器
    • 软体

第 9 章：免疫细胞工程市场 - 按疾病适应症

  • 概述
    • 按疾病适应症分類的细分市场份额分析
    • 心血管疾病
    • 呼吸疾病
    • 传染性疾病
    • 癌症
    • 神经系统疾病
    • 其他的

第 10 章：免疫细胞工程市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 研究应用
    • 细胞治疗与再生医学
    • 其他的

第 11 章：免疫细胞工程市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美免疫细胞工程主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按电池类型）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模与预测（按疾病适应症）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲免疫细胞工程主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按电池类型）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按疾病适应症）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太区免疫细胞工程主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按电池类型）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（依疾病适应症）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲免疫细胞工程主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按电池类型）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按疾病适应症）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲免疫细胞工程主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按电池类型）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（依疾病指示）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第12章：免疫细胞工程产业主要供应商分析

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Lonza
    • Miltenyi Biotec
    • Takara Bio Inc.
    • Sartorius CellGenix GmbH
    • FUJIFILM Irvine Scientific
    • Agilent Technologies, Inc.
    • Bio-Techne
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson and Company
    • Charles River Laboratories
    • Creative Bioarray
    • Sartorius AG
    • Novogene Co, Ltd.
    • AGC Biologics
    • Catalent, Inc.
    • WuXi AppTec
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2400

REPORT HIGHLIGHT

Immune Cell Engineering Market size was valued at USD 2,922.5 Million in 2023, expanding at a CAGR of 20.5% from 2024 to 2032.

Immune cell engineering involves the modification of immune cells like T cells, NK cells, and dendritic cells for both research and therapeutic purposes. These applications range from the development of immunotherapies such as CAR T-cell therapy to the study of immune responses and drug discovery.

Immune Cell Engineering Market- Market Dynamics

Increasing demand for advanced cell therapies to propel market demand

The global market for immune cell engineering offers lucrative prospects for companies operating in the field, given the increasing demand for advanced cell therapies. Therapies employing engineered T cells or chimeric antigen receptor (CAR) T cells have demonstrated promising outcomes in clinical trials for cancer treatment. Key market drivers include significant investments in immunotherapies by major pharmaceutical firms and the expansion of clinical trials focusing on immune cell therapies. The ongoing progress in gene editing, cell isolation, and expansion technologies is substantially fueling the expansion of the immune cell engineering sector. The emergence of effective gene editing tools such as CRISPR/Cas9 has facilitated precise and safer alterations in immune cells. Concurrently, advancements in technologies like microfluidics and high-throughput assays are streamlining cell engineering processes. Moreover, the deepening comprehension of immune cell signaling pathways and interactions is empowering the development of more potent immune cell therapies. These continual technological advancements are anticipated to broaden the horizons and utility of engineered immune cells.

Immune Cell Engineering Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 20.5% over the forecast period (2024-2032)

Based on cell type segmentation, T cells was predicted to show maximum market share in the year 2023

Based on application segmentation, Cell Therapy & Regenerative Medicine was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Immune Cell Engineering Market- Segmentation Analysis:

The Global Immune Cell Engineering Market is segmented on the basis of Cell Type, Product Type, Disease Indication, Application, and Region.

The market is divided into six categories based on Cell Type: T Cells, NK Cells, Dendritic Cells, Tumor Cells, Stem Cells, and others. In the Immune Cell Engineering market, T cells dominate among cell types. T cells are pivotal players in the immune system, possessing the capability to recognize and eliminate infected or cancerous cells. Their dominance stems from their versatile nature and crucial role in various immunotherapeutic approaches, particularly in CAR T-cell therapy. This therapy involves modifying T cells to express chimeric antigen receptors (CARs), enabling them to target and destroy cancer cells with precision. As CAR T-cell therapy gains traction in cancer treatment, the demand for engineered T cells continues to rise, driving their dominance in the market.

The market is divided into three categories based on application: Research Applications, Cell Therapy & Regenerative Medicine, and others. In terms of applications, Cell Therapy & Regenerative Medicine stands out as the dominating segment. This dominance is attributed to the transformative potential of immune cell engineering in developing novel cell-based therapies for various diseases. Cell therapy harnesses the therapeutic potential of engineered immune cells, such as T cells and stem cells, to treat cancer, autoimmune disorders, and regenerative medicine applications. CAR T-cell therapy, in particular, has revolutionized cancer treatment by offering personalized and targeted therapies with remarkable clinical outcomes. Additionally, the field of regenerative medicine utilizes engineered immune cells to repair and regenerate damaged tissues and organs, paving the way for innovative treatment approaches. The significant clinical success and broad therapeutic applications of immune cell-based therapies position Cell Therapy & Regenerative Medicine as the dominant application in the Immune Cell Engineering market.

Immune Cell Engineering Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Immune Cell Engineering Market- Competitive Landscape:

Immune cell engineering companies are adopting strategies focused on innovation, collaboration, and market expansion. They invest in research to enhance therapies like CAR T-cell therapy, forge partnerships for technology exchange, and expand into new markets. These efforts aim to address complexities in personalized therapy development, scale up production capacity, and reduce costs, ultimately aiming for broader patient access. Additionally, they leverage growing clinical evidence and partnerships to drive long-term market evolution in immune cell engineering.Recent Developments:

In August 2023, Astellas Pharma, Inc., a pharmaceutical company, and Poseida Therapeutics, a clinical-stage company, forged a strategic investment agreement to advance the development of cell therapies for cancer. Astellas committed a total of US$ 50 million, including a one-time US$ 25 million payment, to gain exclusive negotiation rights and first refusal to license one of Poseida's clinical-stage programs, P-MUC1C-ALLO1. This program focuses on developing an allogeneic chimeric antigen T cell (CAR-T) therapy for various solid tumor indications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNE CELL ENGINEERING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Thermo Fisher Scientific Inc.

Merck KGaA

Danaher Corporation

Lonza

Miltenyi Biotec

Takara Bio Inc.

Sartorius CellGenix GmbH

FUJIFILM Irvine Scientific

Agilent Technologies, Inc.

Bio-Techne

Bio-Rad Laboratories, Inc.

Becton, Dickinson and Company

Charles River Laboratories

Creative Bioarray

Sartorius AG

Novogene Co, Ltd.

AGC Biologics

Catalent, Inc.

WuXi AppTec

Others

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY CELL TYPE - MARKET ANALYSIS, 2019 - 2032

  • T Cells
  • NK Cells
  • Dendritic Cells
  • Tumor Cells
  • Stem Cells
  • Others

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Consumables
  • Instruments
  • Software

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Diseases
  • Respiratory Diseases
  • Infectious Diseases
  • Cancer
  • Neurological Diseases
  • Others

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Research Applications
  • Cell Therapy & Regenerative Medicine
  • Others

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Immune Cell Engineering Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Immune Cell Engineering Market Snippet by Cell Type
    • 2.1.2.Immune Cell Engineering Market Snippet by Product Type
    • 2.1.3.Immune Cell Engineering Market Snippet by Disease Indication
    • 2.1.4.Immune Cell Engineering Market Snippet by Application
    • 2.1.5.Immune Cell Engineering Market Snippet by Country
    • 2.1.6.Immune Cell Engineering Market Snippet by Region
  • 2.2.Competitive Insights

3.Immune Cell Engineering Key Market Trends

  • 3.1.Immune Cell Engineering Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Immune Cell Engineering Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Immune Cell Engineering Market Opportunities
  • 3.4.Immune Cell Engineering Market Future Trends

4.Immune Cell Engineering Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Immune Cell Engineering Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Immune Cell Engineering Market Landscape

  • 6.1.Immune Cell Engineering Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Immune Cell Engineering Market - By Cell Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
    • 7.1.2.T Cells
    • 7.1.3.NK Cells
    • 7.1.4.Dendritic Cells
    • 7.1.5.Tumor Cells
    • 7.1.6.Stem Cells
    • 7.1.7.Others

8.Immune Cell Engineering Market - By Product Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 8.1.2.Consumables
    • 8.1.3.Instruments
    • 8.1.4.Software

9.Immune Cell Engineering Market - By Disease Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
    • 9.1.2.Cardiovascular Diseases
    • 9.1.3.Respiratory Diseases
    • 9.1.4.Infectious Diseases
    • 9.1.5.Cancer
    • 9.1.6.Neurological Diseases
    • 9.1.7.Others

10.Immune Cell Engineering Market - By Application

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Research Applications
    • 10.1.3.Cell Therapy & Regenerative Medicine
    • 10.1.4.Others

11.Immune Cell Engineering Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Immune Cell Engineering Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Immune Cell Engineering Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Immune Cell Engineering Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Immune Cell Engineering Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Immune Cell Engineering Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Immune Cell Engineering Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Thermo Fisher Scientific Inc.
    • 12.2.2.Merck KGaA
    • 12.2.3.Danaher Corporation
    • 12.2.4.Lonza
    • 12.2.5.Miltenyi Biotec
    • 12.2.6.Takara Bio Inc.
    • 12.2.7.Sartorius CellGenix GmbH
    • 12.2.8.FUJIFILM Irvine Scientific
    • 12.2.9.Agilent Technologies, Inc.
    • 12.2.10.Bio-Techne
    • 12.2.11.Bio-Rad Laboratories, Inc.
    • 12.2.12.Becton, Dickinson and Company
    • 12.2.13.Charles River Laboratories
    • 12.2.14.Creative Bioarray
    • 12.2.15.Sartorius AG
    • 12.2.16.Novogene Co, Ltd.
    • 12.2.17.AGC Biologics
    • 12.2.18.Catalent, Inc.
    • 12.2.19.WuXi AppTec
    • 12.2.20.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immune Cell Engineering Market: Cell Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Immune Cell Engineering Market, by Cell Type 2019-2032 (USD Million)
  • TABLE Immune Cell Engineering Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Immune Cell Engineering Market, by Product Type 2019-2032 (USD Million)
  • TABLE Immune Cell Engineering Market: Disease Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Indication
  • TABLE Global Immune Cell Engineering Market, by Disease Indication 2019-2032 (USD Million)
  • TABLE Immune Cell Engineering Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Immune Cell Engineering Market, by Application 2019-2032 (USD Million)
  • TABLE Immune Cell Engineering Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immune Cell Engineering Market, by Region 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)